Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02048488
Title A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Tesaro, Inc.
Indications

Advanced Solid Tumor

Therapies

Belizatinib

Age Groups: adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Goodyear Arizona United States Details
Scottsdale Arizona United States Details
Los Angeles California United States Details
Nashville Tennessee United States Details
Norfolk Virginia United States Details
Spokane Washington United States Details
Warsaw Mazowieckie Poland Details
Gdansk Pomorskie Poland Details
Olsztyn Warminsko-Mazurskie Poland Details
Poznan Wielkopolskie Poland Details
Madrid Spain Details
Santiago de Compostela Spain Details
Tainan City Taiwan Details
Taipei Taiwan Details
London United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field